Andrew Bell
Impact in
- Oncology top 0.5%
- Viral-associated cancers and disorders
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 59
- Viral-associated cancers and disorders 58
-
- Lymphoma Diagnosis and Treatment 31
- Co-authors
- Alan B. Rickinson (43 shared papers)Stephen Busby (11 shared papers)Gemma L. Kelly (15 shared papers)Claire Shannon‐Lowe (9 shared papers)Martin Rowe (16 shared papers)Kevin Gaston (5 shared papers)Roy M. Williams (5 shared papers)Henri Buc (2 shared papers)
- Journals
- Journal of Virology (18 papers)Blood (10 papers)Journal of General Virology (6 papers)PLoS Pathogens (5 papers)Molecular Microbiology (5 papers)
- Partner nations
- United KingdomAustraliaGermany
In The Last Decade
Andrew Bell
83 papers receiving 4.5k citations
Andrew Bell's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 2.7k
- Pathology and Forensic Medicine 1.4k
- Immunology 1.0k
- Genetics 814
- Infectious Diseases 505
Countries citing papers authored by Andrew Bell
This map shows the geographic impact of Andrew Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bell more than expected).
Fields of papers citing papers by Andrew Bell
This network shows the impact of papers produced by Andrew Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bell. The network helps show where Andrew Bell may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Bell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epstein–Barr virus-associated lymphomas Hit paper breakdown → | 2017 | 295 |
| 2 | 1990 | 235 | |
| 3 | 2002 | 168 | |
| 4 | 1990 | 160 | |
| 5 | 2009 | 137 | |
| 6 | 1996 | 116 | |
| 7 | 2003 | 116 | |
| 8 | 1997 | 109 | |
| 9 | 2006 | 105 | |
| 10 | 2006 | 96 | |
| 11 | 2009 | 96 | |
| 12 | 2010 | 90 | |
| 13 | 2005 | 84 | |
| 14 | 1989 | 83 | |
| 15 | 2015 | 83 | |
| 16 | 2009 | 80 | |
| 17 | 1999 | 79 | |
| 18 | 1994 | 79 | |
| 19 | 2009 | 78 | |
| 20 | 1991 | 76 |
About Andrew Bell
Andrew Bell is a scholar working on Oncology, Pathology and Forensic Medicine, Infectious Diseases, Immunology and Molecular Biology, having authored 83 papers that have together received 4.5k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (58 papers), Lymphoma Diagnosis and Treatment (31 papers), Immune Cell Function and Interaction (18 papers), Parvovirus B19 Infection Studies (17 papers), Cytomegalovirus and herpesvirus research (11 papers), Bacterial Genetics and Biotechnology (10 papers), Eosinophilic Disorders and Syndromes (9 papers) and Histiocytic Disorders and Treatments (7 papers). The work is most often cited by research in Oncology (2.7k citations), Pathology and Forensic Medicine (1.4k citations), Immunology (1.0k citations), Genetics (814 citations) and Infectious Diseases (505 citations). Andrew Bell has collaborated with scholars based in United Kingdom, Australia and Germany. Frequent co-authors include Alan B. Rickinson, Stephen Busby, Gemma L. Kelly, Claire Shannon‐Lowe, Martin Rowe, Kevin Gaston, Roy M. Williams, Henri Buc, Annie Kolb and Rosemary J. Tierney. Their work appears in journals such as Journal of Virology, Blood, Journal of General Virology, PLoS Pathogens and Molecular Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.